Alprazolam and Skin atrophy - a phase IV clinical study of FDA data

Summary:

Skin atrophy is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Fish Oil, and have Pain.

The phase IV clinical study analyzes which people have Skin atrophy when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Skin atrophy?

Skin atrophy (wasting of skin) is found to be associated with 623 drugs and 718 conditions by eHealthMe. Check the latest studies of Skin atrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 45 people (0.03%) have Skin atrophy.

Among these 45 people:

How long have people been on Alprazolam when they have Skin atrophy? *

What is the gender of people who have Skin atrophy when taking Alprazolam? *

female: 75.56 %
male: 24.44 %

What is the age of people who have Skin atrophy when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

What are other side effects people have besides Skin atrophy? *

Head Injury: 18 people, 40.00%
Pain: 14 people, 31.11%
Joint Pain: 13 people, 28.89%
Pain In Extremity: 12 people, 26.67%
Rashes (redness): 11 people, 24.44%
Hair Loss: 11 people, 24.44%
Fatigue (feeling of tiredness): 11 people, 24.44%
Skin Disorder (skin disease): 10 people, 22.22%
Feeling Abnormal: 9 people, 20.00%
Back Pain: 9 people, 20.00%

What are the existing conditions these people have? *

Pain: 7 people, 15.56%
High Blood Cholesterol: 6 people, 13.33%
Osteoporosis (bones weak and more likely to break): 5 people, 11.11%
Depression: 4 people, 8.89%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 6.67%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 6.67%
Renal Cell Carcinoma (a kidney cancer): 3 people, 6.67%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Skin atrophy?

- Check whether Skin atrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Skin atrophy treatments and more:

Skin atrophy (6,670 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin atrophy:

Skin atrophy (623 drugs)

Browse all the conditions that are associated with Skin atrophy:

Skin atrophy (718 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.